Japanese Government Procurement

National University Corporation - Notice of Procurement (Goods & Services)A Nusinersen Sodium, SPINRAZA Intrathecal Injection 12mg (5ml×1) 60 cases,Ｂ　Nivolumab (Genetical Recombination), OPDIVO Intravenous Infusion 240mg (24mL×1) 760 cases,Ｃ　Viltolarsen, VILTEPSO Intravenous Infusion 250mg (5ml×1) 2,640 cases,Ｄ　Pembrolizumab (Genetical Recombination), KEYTRUDA In...

This procurement is covered by the WTO Agreement on Government Procurement, Japan-EU Economic Partnership Agreement or Japan-UK Comprehensive Economic Partnership Agreement.

Japanese

Publishing date Jan 21, 2021
Type of notice Notice of Procurement (Goods & Services)
Procurement entity National University Corporation - Kagoshima
Classification
0004 Medical & Pharmaceutical Products
Summay of notice ⑴ Official in charge of disbursement of the procuring entity : Hiroaki Yamaki, Executive Vice President Financial Affairs, National University Corporation Kagoshima University
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased :
A Nusinersen Sodium, SPINRAZA Intrathecal Injection 12mg (5ml×1) 60 cases
B Nivolumab (Genetical Recombination), OPDIVO Intravenous Infusion 240mg (24mL×1) 760 cases
C Viltolarsen, VILTEPSO Intravenous Infusion 250mg (5ml×1) 2,640 cases
D Pembrolizumab (Genetical Recombination), KEYTRUDA Injection 100mg (4ml×1) 800 cases
E Lenalidomide hydrate capsules, Revlimid 5mg (10capsules×4) 200 cases
F Ravulizumab (Genetical Recombination), ULTOMIRIS for Intravenous Infusion 300mg (30ml×1) 60 cases
G Temcell HS Injection (10.8ml×1) 48 pieces
⑷ Delivery period : From 1 April, 2021 through 31 March, 2022
⑸ Delivery place : Kagoshima University Hospital
⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
A not come under Article 2 and 3 of the Regulation concerning the Contract for Kagoshima University,
B have the Grade A, Grade B, Grade C or Grade D qualification during fiscal 2020 in the Kyushu・Okinawa area in sales of product for participating in tenders by Single qualification for every ministry and agency, or have the Grade A, Grade B, Grade C or Grade D qualification during fiscal 2020 in sales of product for participating in tenders by National University Corporation Kagoshima University,
C prove to have obtained the first-class license for selling drugs in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices,
D meet the qualification requirements which Executive Vice President Financial Affairs, National University Corporation Kagoshima University may specify in accordance with Article 4, section 6 of the Regulation concerning the Goods supply contract for Kagoshima University,
E not be currently under a suspension of business order as instructed by Executive Vice President Financial Affairs, National University Corporation Kagoshima University.
⑺ Time limit of tender : 17 : 00 15 March, 2021
⑻ Contact point for the notice : Yuji Arikawa, Procurement Section, Accounting Division, Finance Department, National University Corporation Kagoshima University, 1-21-24 Korimoto Kagoshima-shi 890-8580 Japan, TEL 099-285-7153
⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents.